What is the recommended dose of Ryaltris (olopatadine hydrochloride and mometasone furoate) for a 12-year-old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

Directions adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours The recommended dose of Ryaltris for a 12-year-old patient is 1 tablet daily, not more than 1 tablet in 24 hours 1.

From the Research

For a 12-year-old, the standard dose of Ryaltris (olopatadine hydrochloride and mometasone furoate nasal spray) is typically one spray in each nostril twice daily. This medication is approved for children 6 years and older at the same dosage as adults. Each spray delivers 665 mcg of olopatadine hydrochloride and 25 mcg of mometasone furoate. Before use, the bottle should be primed with 6 sprays or until a fine mist appears. The child should gently blow their nose before administration, then tilt their head slightly forward, insert the spray tip into one nostril while blocking the other, and breathe in gently while spraying. This should be repeated for the other nostril. Ryaltris combines an antihistamine (olopatadine) that blocks allergy symptoms and a corticosteroid (mometasone) that reduces inflammation, making it effective for seasonal allergic rhinitis. Side effects may include nose bleeds, nasal discomfort, or altered taste. The medication should be used regularly as prescribed for maximum effectiveness, even when symptoms improve, as supported by studies such as 2.

Some key points to consider when administering Ryaltris include:

  • The importance of proper administration technique to ensure the medication reaches the nasal mucosa effectively.
  • The potential for side effects, which are generally mild and transient.
  • The need for regular use to maintain therapeutic effects, as noted in studies like 3.
  • The combination of an antihistamine and a corticosteroid in Ryaltris provides a comprehensive approach to managing allergic rhinitis symptoms, as discussed in 4.

It's also worth noting that while other medications like azelastine have been studied for their efficacy in allergic rhinitis, as seen in 5, the specific formulation and dosage of Ryaltris make it a unique treatment option. Overall, the recommended dose of Ryaltris for a 12-year-old patient is one spray in each nostril twice daily, with proper administration and regular use being key to maximizing its therapeutic benefits.

References

Research

Comparison of the Effects of Azelastine and Fluticasone Nasal Sprays in the Treatment of Allergic Rhinitis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022

Research

Intranasal spray medications for maintenance therapy of allergic rhinitis.

American journal of rhinology & allergy, 2015

Research

New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.

Recent patents on inflammation & allergy drug discovery, 2013

Research

Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.